In addition, in vitro studies suggest that FGF23 can induce endothelial dysfunction in the setting of klotho deficiency via enhanced ROS production and suppression of antioxidant enzymes resulting in increased oxidative stress, which in turn may contribute to the progression of cardiovascular disease in humans. This evidence concerns the gene FGF23 and endothelial dysfunction.